Medial EarlySign

Current Time Inside Cache Tag Helper: 9/19/2020 9:38:29 PM and Model.VendorId = 68481

Medial EarlySign's Current COVID-19 Response and Solutions

The following information was supplied by the vendor and has not been validated by KLAS.

AlgoAnalyzer

Identifies patients estimated to be at increased risk of suffering severe complications if infected with coronavirus

EarlySign Invites you to Discover our COVID-19 Complications Risk Predictor

We have seen how COVID-19 negatively impacts the community and creates a massive burden to the health system. With emotional distress, significant economic anxiety, and physical suffering for individuals, early action is critical.

Working together with health system partners around the world, EarlySign’s new AI-based clinical risk predictor has been shown to identify patients estimated to be at increased risk of suffering severe complications if infected with coronavirus. With the goal of prioritizing patients for COVID-19 testing and treatment, the new AlgoMarker aids in speeding the determination whether patients are at high risk for hospitalization, complications, and mortality.

The result: More patients at high risk see their medical conditions addressed earlier and essential clinical resources are used more efficiently and effectively.

“Immediate action is critical to combat this pandemic, and we are taking urgent steps to massively impact human health,” stated EarlySign CEO Jeremy Orr, MD, MPH. “Our goal is to provide health systems a fast, reliable approach to identify and connect with patients at highest risk. We believe it to our shared mission to make this available at no cost or obligation.”



Current Time Inside Cache Tag Helper: 9/19/2020 9:38:30 PM and Model.VendorId = 68481

Software Overall Score Data collected between Sep 2019 - Sep 2020

##.#

 Product
Segment